Radboudumc
Hospitals & Physicians Clinics · Netherlands · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Geert Grooteplein Zuid 10, Nijmegen, Gel...Phone Number
+31 243611111Website
www.radboudumc.nlRevenue
$2.7 BillionIndustry
About Radboudumc
Radboudumc Org Chart
Manager
Manager
Manager
Manager
Manager
Manager
Manager
Manager
Manager
Sales Manager
Is Radboudumc your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Radboudumc recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Radboudumc
Check if Radboudumc has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Radboudumc had a recent Job posting/layoffs
Radboudumc, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Radboudumc is spiking on competitors!
Funding: Get notified immidiatlly once Radboudumc has new funding data
Product Launch: Get notified when Radboudumc launches new products
Recommended Actions
Find VP level buyers at Radboudumc
Find 2 more new buyers
Company Profile Activity
Activity Insights
Radboudumc is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Radboudumc is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Radboudumc.
Radboudumc Tech Stack
A closer look at the technologies used by Radboudumc
Most Recent Scoops
Radboudumc News & Media
Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks' proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform TGW211 is designed to achieve strong tumor uptake with selective and rapid elimination of...Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks' proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform TGW211 is designed to achieve strong tumor uptake with selective and rapid elimination of...
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding Radboudumc
Radboudumc is one of eight University Medical Centres in The Netherlands, founded in 1951. The institution is devoted to patient care, education, training, and conducting basic and clinical research. Radboudumc focuses on delivering participatory and personalized healthcare through innovative medical services and research and development initiative... Read More